Literature DB >> 16162776

Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis.

Anan Wattanathum1, Sanjay Manocha, Horacio Groshaus, James A Russell, Keith R Walley.   

Abstract

STUDY
OBJECTIVE: To test the hypothesis that haplotypes of the interleukin (IL)-10 gene are associated with clinical outcomes, comparing critically ill patients with sepsis from pneumonia vs those with extrapulmonary sepsis.
DESIGN: Genetic association study.
SETTING: Medical/surgical ICUs in a tertiary-care, university-affiliated teaching hospital. PATIENTS: Of 550 white patients with sepsis, 158 had pneumonia as the principle cause of their sepsis and 392 had an extrapulmonary source of sepsis. MEASUREMENTS: Haplotypes of the IL-10 gene were defined by measurement of haplotype tag single-nucleotide polymorphisms (SNPs). Primary outcome was 28-day survival. Secondary outcomes were days alive and free of organ dysfunction.
RESULTS: Three SNPs in the IL-10 gene (-592 C/A, +734 G/T, and +3367 G/A) identified four major haplotypes: CGG, AGG, CTA, and CTG. Patients with pneumonia who carried one or two copies of the CGG haplotype had greater 28-day mortality (51.4%) than patients who did not carry this haplotype (29.1%, p = 0.007). Carriers of CGG had significantly more cardiovascular dysfunction (and use of vasopressors), renal dysfunction (and requirement of dialysis), hepatic dysfunction, and hematologic dysfunction (p < 0.05 in each case). In contrast, in patients with an extrapulmonary source of infection there was no significant association of the CGG haplotype (or any measured IL-10 genotype) with 28-day mortality or organ dysfunction.
CONCLUSIONS: The IL-10 haplotype - 592C/734G/3367G is associated with increased mortality and organ dysfunction in critically ill patients with pulmonary sepsis but not in similarly ill patients with extrapulmonary sepsis. Therefore, polymorphisms within the IL-10 gene may be predictors of outcome in patients with sepsis from pneumonia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162776     DOI: 10.1378/chest.128.3.1690

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  19 in total

Review 1.  Acute lower respiratory tract infection.

Authors:  Joseph P Mizgerd
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

2.  A nonsynonymous polymorphism of IRAK4 associated with increased prevalence of gram-positive infection and decreased response to toll-like receptor ligands.

Authors:  Ainsley M Sutherland; Keith R Walley; Taka-Aki Nakada; Andy H P Sham; Mark M Wurfel; James A Russell
Journal:  J Innate Immun       Date:  2011-05-14       Impact factor: 7.349

Review 3.  Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways.

Authors:  Anil Sapru; Joseph L Wiemels; John S Witte; Lorraine B Ware; Michael A Matthay
Journal:  Intensive Care Med       Date:  2006-06-13       Impact factor: 17.440

4.  Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?

Authors:  B D Freeman; C R Kennedy; H L Frankel; B Clarridge; D Bolcic-Jankovic; E Iverson; E Shehane; A Celious; B A Zehnbauer; T G Buchman
Journal:  Pharmacogenomics J       Date:  2009-12-08       Impact factor: 3.550

Review 5.  Searching for genes that matter in acute kidney injury: a systematic review.

Authors:  Jonathan C T Lu; Steven G Coca; Uptal D Patel; Lloyd Cantley; Chirag R Parikh
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

Review 6.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

7.  Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis.

Authors:  Mark M Wurfel; Anthony C Gordon; Tarah D Holden; Frank Radella; Jeanna Strout; Osamu Kajikawa; John T Ruzinski; Gail Rona; R Anthony Black; Seth Stratton; Gail P Jarvik; Adeline M Hajjar; Deborah A Nickerson; Mark Rieder; Jonathan Sevransky; James P Maloney; Marc Moss; Greg Martin; Carl Shanholtz; Joe G N Garcia; Li Gao; Roy Brower; Kathleen C Barnes; Keith R Walley; James A Russell; Thomas R Martin
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

Review 8.  Genetic susceptibility to inflammatory injury and various adverse outcomes.

Authors:  John M Murkin; Keith R Walley
Journal:  J Extra Corpor Technol       Date:  2009-03

Review 9.  Bench-to-bedside review: Association of genetic variation with sepsis.

Authors:  Ainsley M Sutherland; Keith R Walley
Journal:  Crit Care       Date:  2009-04-29       Impact factor: 9.097

Review 10.  The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy.

Authors:  Jean-Paul Mira; Adeline Max; Pierre-Regis Burgel
Journal:  Crit Care       Date:  2008-11-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.